These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 4878860)
1. Etiology of the stimulant nature of the schizophrenias. Pfeiffer CC; Beck RA; Goldstein L; Neiss ES Recent Adv Biol Psychiatry; 1966; 9():241-9. PubMed ID: 4878860 [No Abstract] [Full Text] [Related]
2. Methylation & schizophrenia. Beaton JM Ala J Med Sci; 1975 Apr; 12(2):193-202. PubMed ID: 1096652 [No Abstract] [Full Text] [Related]
3. [Relation of monoamines to mental disorders]. Rysánek K Act Nerv Super (Praha); 1970; 12(2):97-108. PubMed ID: 4913937 [No Abstract] [Full Text] [Related]
4. Biogenic amines and psychiatry. Aust N Z J Psychiatry; 1971 Mar; 5(1):4-9. PubMed ID: 4946453 [No Abstract] [Full Text] [Related]
5. Indolealkylamines and behavior. Airaksinen MM; McIsaac WM Ann Med Exp Biol Fenn; 1968; 46(3):367-81. PubMed ID: 4896939 [No Abstract] [Full Text] [Related]
6. Biochemical abnormalities associated with schizophrenia. Smythies JR Br J Psychiatry; 1975; Spec No 9():41-7. PubMed ID: 1102037 [No Abstract] [Full Text] [Related]
7. [Schizophrenia and cerebral amines]. Véron JP; Kezirian S Presse Med (1893); 1971 Oct; 79(44):1973-4. PubMed ID: 5119550 [No Abstract] [Full Text] [Related]
8. A biochemical survey of schizophrenia. Brodsky L Can Psychiatr Assoc J; 1970 Aug; 15(4):375-88. PubMed ID: 4915174 [No Abstract] [Full Text] [Related]
9. Nicotinic acid and catechol-O-methyl-transferase activity in schizophrenia. Ban TA; Lehmann HE; Klingner A Int J Clin Pharmacol; 1973 Feb; 7(1):44-7. PubMed ID: 4699383 [No Abstract] [Full Text] [Related]
10. A consideration of biological factors in schizophrenia. Ipton MA Proc Annu Meet Am Psychopathol Assoc; 1969; 58():310-33. PubMed ID: 4898740 [No Abstract] [Full Text] [Related]
12. Biochemistry and the schizophrenias. Smythies JR South Med J; 1979 Oct; 72(10):1272-6. PubMed ID: 39348 [TBL] [Abstract][Full Text] [Related]
13. Abnormal O-methylated dopamine metabolites: the endogenous toxins of schizophrenia or parkinsonism? Smith JA; Hartley R J Pharm Pharmacol; 1973 May; 25(5):415-6. PubMed ID: 4146400 [No Abstract] [Full Text] [Related]
14. Blood flow and oxidative metabolism of the brain in patients with schizophrenia. Hoyer S; Oesterreich K Psychiatr Clin (Basel); 1975; 8(6):304-13. PubMed ID: 1233537 [TBL] [Abstract][Full Text] [Related]
16. Comments on a proposed mechanism of formation of the "schizophrenic odor factor". Grant FW Res Commun Chem Pathol Pharmacol; 1973 Jul; 6(1):335-6. PubMed ID: 4734009 [No Abstract] [Full Text] [Related]
17. Ouabain and the membrane transport of amino acids and amines. Curtis DR Neurochem Res; 1987 Aug; 12(8):755-7. PubMed ID: 3627363 [TBL] [Abstract][Full Text] [Related]
18. The peripheral and central actions of some anticholinergic substances. Brimblecombe RW; Green DM Int J Neuropharmacol; 1968 Jan; 7(1):15-21. PubMed ID: 5639303 [No Abstract] [Full Text] [Related]
19. [Contribution to the study of the central effects of hallucinogenic and psychotomimetic medicines]. Longo VG Actual Neurophysiol (Paris); 1967; 7():203-16. PubMed ID: 6043096 [No Abstract] [Full Text] [Related]
20. Failure of N,N-dimethyltryptamine to evoke tolerance in cats. Gillin JC; Cannon E; Magyar R; Schwartz M; Wyatt RJ Biol Psychiatry; 1973 Dec; 7(3):213-20. PubMed ID: 4519415 [No Abstract] [Full Text] [Related] [Next] [New Search]